GOJO takes action after FDA letter

US jan/san manufacturer GOJO responded swiftly to a warning letter from the US Food and Drug Administration (FDA) in January.

0

To continue reading this article, you must have a paid membership.

Join now from just £5


Existing paying members, please log in to access the full story.

 

If you are not a paying member, sign up now: